AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitayes-M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Morepen Laboratories Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitayes-M 50mg/500mg Tablet

Diabexe Duo 50mg/500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lowering heart attack and stroke risks. Diabexe Duo may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood sugar readings, and current medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily dosing, at the same time each day, maximizes efficacy; discontinue only under your physician's guidance. Adherence to your prescribed diet and exercise plan is crucial. Lifestyle choices significantly impact diabetes control. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and pharyngitis. Low blood sugar (hypoglycemia) is a potential side effect, especially when combined with insulin or sulfonylureas; learn to identify and manage this. This medication isn't suitable for all. Inform your doctor of any prior kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol consumption. Pregnant or lactating individuals should seek medical advice before use. Interactions with other drugs are possible; disclose all medications to ensure safety. Alcohol should be limited due to its hypoglycemic effects. Your doctor will monitor kidney function and blood glucose levels throughout treatment.

Uses of Sitayes-M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Sitayes-M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet; do not chew, crush, or fracture it. The Sitayes-M 50mg/500mg tablet should be administered with food.

Common Side effects of Sitayes-M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitayes-M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. It is recommended to take the Sitayes-M 50mg/500mg tablet with food.

How Sitayes-M 50mg/500mg Tablet works:

Sitagliptin/metformin 50mg/500mg tablets (brand name example: Sitayes-M) combine two medications to manage blood sugar. Sitagliptin boosts insulin production by the pancreas, improves insulin utilization, and lessens the liver's glucose output. Metformin, a biguanide, reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness. This dual action offers superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Sitayes-M 50mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitayes-M 50mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the potential advantages against the risks prior to prescribing. Medical advice is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitayes-M 50mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitayes-M 50mg/500mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Sitayes-M 50mg/500mg tablets are contraindicated in those with severe kidney disease. Routine monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

The use of Sitayes-M 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitayes-M 50mg/500mg Tablet :

Should you forget a Sitayes-M 50mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitayes-M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitayes-M 50mg/500mg Tablet

Sitayes-M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Sitayes-M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, supplemental vitamin B12 intake is recommended annually by some researchers.
Sitayes-M 50mg/500mg tablets may cause common side effects including low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis can occur. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Sitayes-M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitayes-M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (Sitayes-M 50mg/500mg) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms occur, discontinue Sitayes-M and seek immediate medical attention.
Sitayes-M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitayes-M 50mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients allergic to Sitayes-M 50mg/500mg Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Sitayes-M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Sitayes-M 50mg/500mg) can rarely cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also called Metformin-associated lactic acidosis or MALA). This risk is higher in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitayes-M 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the label's storage instructions. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitayes-M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitayes-M 50mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitayes-M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol and Sitayes-M 50mg/500mg tablets is unsafe due to an increased risk of lactic acidosis.
Sitagliptin/Metformin (Sitayes-M 50mg/500mg) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding Sitayes-M in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitayes-M and seek immediate medical attention.
Prolonged Sitayes-M 50mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitayes-M 50mg/500mg Tabl...
333